Log in to save to my catalogue

Assessment of clinical data on urocortins and their therapeutic potential in cardiovascular diseases...

Assessment of clinical data on urocortins and their therapeutic potential in cardiovascular diseases...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_141ce98328b344d28f6d9a2d310ae716

Assessment of clinical data on urocortins and their therapeutic potential in cardiovascular diseases: A systematic review and meta‐analysis

About this item

Full title

Assessment of clinical data on urocortins and their therapeutic potential in cardiovascular diseases: A systematic review and meta‐analysis

Publisher

United States: John Wiley & Sons, Inc

Journal title

Clinical and translational science, 2021-11, Vol.14 (6), p.2461-2473

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Heart failure (HF) and cardiovascular diseases present public health challenges. Although great progress was achieved in their treatment, there is continuous need for new therapies. Urocortins of the corticotropin neuropeptide family were reported to exert beneficial effects in animal models of HF and cardiovascular diseases. We aimed to assess the...

Alternative Titles

Full title

Assessment of clinical data on urocortins and their therapeutic potential in cardiovascular diseases: A systematic review and meta‐analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_141ce98328b344d28f6d9a2d310ae716

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_141ce98328b344d28f6d9a2d310ae716

Other Identifiers

ISSN

1752-8054

E-ISSN

1752-8062

DOI

10.1111/cts.13114

How to access this item